1. |
Arroyo S, Brodie MJ, Avanzini G, et al. Is refractory epilepsy preventable? Epilepsia, 2002, 43(4): 437-444.
|
2. |
Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med, 2000, 342(5): 314-319.
|
3. |
Kwan P, Brodie MJ. Definition of refractory epilepsy: defining the indefinable? Lancet Neurol, 2010, 9(1): 27-29.
|
4. |
Regesta G, Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res, 1999, 34(2-3): 109-122.
|
5. |
Luna-Tortos C, Fedrowitz M, Loscher W. Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology, 2008, 55(8): 1364-1375.
|
6. |
Luna-Tortos C, Rambeck B, Jurgens UH, et al. The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance proteins. Pharm Res, 2009, 26(11): 2464-2470.
|
7. |
Volk HA, Loscher W. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain, 2005, 128(Pt 6): 1358-1368.
|
8. |
Baumert C, Hilgeroth A. Recent advances in the development of P-gp inhibitors. Anticancer Agents Med Chem, 2009, 9(4): 415-436.
|
9. |
Fox E, Bates SE. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor. Expert Rev Anticancer Ther, 2007, 7(4): 447-459.
|
10. |
Fang ZY, Chen SD, Chen YS, et al. Pluronic P85 enhances the delivery of phenytoin to the brain versus verapamil in vivo. Latin Am J Pharm, 2014, 33(5): 812-818.
|
11. |
Fang Z, Chen S, Qin J, et al. Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy. Biomaterials, 2016, 97: 110-121.
|
12. |
Brandt C, Bethmann K, Gastens AM, et al. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis, 2006, 24(1): 202-211.
|
13. |
Volk HA, Arabadzisz D, Fritschy JM, et al. Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABA(A) receptor ligand binding in a model of temporal lobe epilepsy. Neurobiol Dis, 2006, 21(3): 633-646.
|
14. |
方子妍, 郭彩凤, 吴逢春, 等. Tariquidar 提高苯妥英钠在颞叶内侧癫痫模型鼠脑中的分布. 临床医学工程, 2017, 24(6): 762-764.
|
15. |
Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol, 1972, 32(3): 281-294.
|
16. |
方子妍, 郭彩凤, 吴逢春, 等. 普朗尼克 P85 修饰的苯妥英钠纳米粒对颞叶内侧癫痫大鼠模型的脑靶向作用. 中国神经精神疾病杂志, 2017, 43(6): 356-361.
|
17. |
陈树达, 陈子怡, 方子妍, 等. 普朗尼克 P85 与维拉帕米对苯妥英钠脑靶向分布的比较. 中山大学学报 (医学科学版), 2014, 35(2): 161-168.
|
18. |
Ledwitch KV, Roberts AG. Cardiovascular ion channel inhibitor drug-drug interactions with P-glycoprotein. AAPS J, 2017, 19(2): 409-420.
|